XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenue $ 43,258 $ 31,643 $ 21,655
Cost of sales (11,810) (12,867) (13,463)
Gross profit 31,448 18,776 8,192
Research and development costs (67,883) (56,937) (43,550)
General and administrative expenses (26,884) (26,222) (25,682)
Operating loss (63,319) (64,383) (61,040)
Foreign currency gain/(loss), net 646 (2,641) 1,294
Other income, net 4,472 1,803 280
Benefit from R&D credit 13,737 11,949 9,820
Loss before income tax expense (44,464) (53,272) (49,646)
Income tax expense (845) (956) (688)
Net Loss $ (45,309) $ (54,228) $ (50,334)
Loss per share basic $ (0.33) $ (0.49) $ (0.52)
Loss per share diluted $ (0.33) $ (0.49) $ (0.52)
Weighted-average shares outstanding basic 138,752,224 111,277,250 96,584,512
Weighted-average shares outstanding diluted 138,752,224 111,277,250 96,584,512